Osaic Holdings’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Osaic Holdings’s Portfolio FNCH Stock Details FNCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-8	Closed	-$96	–	7668
2023 Q1	$96	Hold	8	–	–	﹤0.01%	7336
2022 Q4	$0	Sell	8 -27	-77%	-$903	﹤0.01%	7590
2022 Q3	$2K	Buy	35 +4	+13%	+$278	﹤0.01%	6892
2022 Q2	$3K	Buy	31 +30	+3,000%	+$2.57K	﹤0.01%	6803
2022 Q1	$41K	Hold	1	–	–	﹤0.01%	5243
2021 Q4	$0	Buy	+1	New	+$383	﹤0.01%	7694
2021 Q3	–	Hold	0	–	–	–	7413
2021 Q2	–	Hold	0	–	–	–	7206

Other funds holding FNCH

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

AMC

Avenir Management Company New York $43.8M AUM 101.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSAG

Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Osaic Holdings's FNCH Position: Q2 2023 in Review

Osaic Holdings sold out of Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q2 2023, closing a stake of 8 shares — an estimated $96 sold.

Osaic Holdings first reported a position in FNCH in Q4 2021 and held it in 6 quarters. The position peaked at $41K in Q1 2022. 17 funds tracked by Wall St. Rank hold FNCH as of Q2 2023.

Osaic Holdings reported no remaining Finch Therapeutics Group, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Osaic Holdings sold 8 Finch Therapeutics Group, Inc. Common Stock shares in Q2 2023, an estimated $96.
Osaic Holdings first reported a position in Finch Therapeutics Group, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
Osaic Holdings's Finch Therapeutics Group, Inc. Common Stock position peaked at $41K in Q1 2022.
17 funds tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q2 2023.

Based on Osaic Holdings's 13F filing for Q2 2023, filed 10 Aug 2023.